Neurocysticercosis is one of the most important — and most preventable — infectious causes of epilepsy worldwide. It occurs when the larval stage of the pork tapeworm Taenia solium reaches the central nervous system and forms cysts in the brain or surrounding tissues.
The condition is especially important in parts of Latin America, sub-Saharan Africa, South Asia and South-East Asia, although migration and travel mean cases can also appear in countries where transmission is uncommon.
WHO describes neurocysticercosis as the most frequent preventable cause of epilepsy worldwide. In many endemic areas, T. solium infection is estimated to account for around 30% of epilepsy cases, although the proportion varies greatly between communities.
Neurocysticercosis is not acquired simply by eating pork
This is one of the most commonly misunderstood points.
Eating raw or undercooked pork containing T. solium cysts can cause taeniasis: an adult tapeworm living in the intestine. Neurocysticercosis occurs through a different route. A person develops cysticercosis after swallowing T. solium eggs, usually through faecal contamination of food, water, hands or the environment.
Those eggs hatch, the larvae cross the intestinal wall, travel through the bloodstream and can lodge in tissues including the brain.
A person who never eats pork can still develop neurocysticercosis
Because cysticercosis is acquired by ingesting tapeworm eggs rather than pork cysts, avoiding pork does not completely eliminate risk if there is environmental contamination from a human tapeworm carrier.
This is why neurocysticercosis can occur in people whose religion, culture or diet excludes pork.
The key transmission source is a person carrying the adult T. solium tapeworm and shedding eggs in faeces.
Humans are central to the transmission cycle
Pigs are the usual intermediate host. They become infected when they ingest T. solium eggs from human faecal contamination. Larval cysts develop in the pig’s tissues. Humans then develop intestinal taeniasis after eating inadequately cooked infected pork.
The adult tapeworm in the human intestine produces eggs, which are passed in faeces. Those eggs can infect pigs — or another human.
This creates a cycle linking sanitation, human infection, pig husbandry and food safety.
Why the brain is affected
After T. solium eggs are ingested, larvae can migrate through the circulation and form cysts in several tissues. When this happens within the central nervous system, the condition is called neurocysticercosis.
Cysts can occur within brain tissue, the ventricles, the subarachnoid space or other locations. Their clinical effects depend on where they are, how many are present, what stage they have reached and how the immune system responds.
This means neurocysticercosis is not one uniform disease.
Many infections remain silent for years
People can remain asymptomatic for long periods after infection. Living cysts may initially trigger relatively little inflammation.
Symptoms often emerge when cysts begin to degenerate and the immune system reacts more strongly. This inflammatory response can cause surrounding oedema and provoke seizures.
The delay between infection and neurological symptoms can make the source of infection difficult to recognise.
Seizures are the most common neurological presentation
Seizures are one of the most frequent clinical manifestations of neurocysticercosis. They may occur as acute symptomatic seizures during active inflammation, or recurrent unprovoked seizures may develop and meet criteria for epilepsy.
The distinction matters because not every seizure caused by neurocysticercosis automatically means lifelong epilepsy.
Some people become seizure-free after the inflammatory lesion resolves, while others continue to have epilepsy because the infection has left a persistent epileptogenic scar or calcification.
Calcified lesions are not always inactive
After a cyst dies, it may calcify. Calcification was once often treated as an inert endpoint, but research has shown that some calcified lesions remain clinically relevant.
Perilesional inflammation and oedema can occur around calcified cysts and may be associated with recurrent seizures.
A calcified lesion therefore does not necessarily mean the neurological story is over.
Inflammation is central to seizure generation
Much of the seizure risk in neurocysticercosis is linked not simply to the physical presence of the parasite but to the host inflammatory response around degenerating lesions.
Inflammation can alter excitability in surrounding brain tissue and create a temporary or persistent seizure focus.
This is one reason treatment decisions can involve corticosteroids as well as antiparasitic drugs and antiseizure medication.
Not everyone with neurocysticercosis develops epilepsy
The clinical spectrum ranges from completely asymptomatic infection to severe neurological disease.
Risk depends on lesion number, location, developmental stage, surrounding inflammation and individual host response. Some people have a single lesion and one seizure. Others develop recurrent seizures, hydrocephalus or more complex neurological syndromes.
This variability makes individual prognosis difficult to predict from the diagnosis alone.
Different forms of neurocysticercosis behave differently
Parenchymal neurocysticercosis involves lesions within the brain tissue itself and is strongly associated with seizures.
Extraparenchymal disease can involve the ventricular system or subarachnoid spaces and may cause hydrocephalus, raised intracranial pressure, cranial nerve problems or other serious complications.
The treatment approach differs substantially between these forms, which is why specialist assessment matters.
Single enhancing lesions are common in some endemic regions
In parts of South Asia, a common presentation is a solitary cysticercus granuloma or single enhancing lesion associated with seizures.
These cases may behave differently from heavy multicystic disease and can have a relatively favourable seizure prognosis after the lesion resolves.
However, imaging interpretation is essential because other infections and tumours can mimic a similar appearance.
Heavy infection can produce very different disease
Some people have many viable or degenerating cysts. Others have subarachnoid or ventricular disease that behaves more like chronic meningitis or an obstructive process than a simple seizure disorder.
These forms can require prolonged anti-inflammatory treatment, repeated antiparasitic therapy, neurosurgical procedures or management of hydrocephalus.
It would therefore be inaccurate to describe neurocysticercosis as simply ‘a tapeworm that causes seizures’.
CT and MRI provide different information
Neuroimaging is central to diagnosis. CT is particularly good at demonstrating calcification and can be widely available in some endemic settings.
MRI provides better visualisation of many viable cysts, inflammation, oedema, ventricular lesions and subarachnoid disease.
The two modalities are often complementary rather than interchangeable.
The scolex can be a key imaging clue
A cyst containing the visible scolex — the larval head of the parasite — can be highly characteristic on imaging.
However, not every lesion shows this feature, and lesions change appearance as they evolve.
Diagnosis therefore depends on the complete imaging pattern, clinical context, epidemiology and sometimes serological testing.
Serology can support diagnosis but is not perfect
Antibody tests can help support the diagnosis, particularly in people with multiple viable lesions. Sensitivity is lower in some people with a single lesion or only calcified disease.
A positive antibody result also indicates exposure and does not by itself prove that every brain lesion seen on imaging is caused by neurocysticercosis.
Serology is therefore interpreted alongside imaging rather than replacing it.
Diagnostic criteria combine several kinds of evidence
Modern diagnostic approaches use combinations of neuroimaging, immunological testing, clinical features and epidemiological context.
This is important because there is no single test that perfectly diagnoses every form of neurocysticercosis.
Expert interpretation reduces both missed diagnoses and inappropriate antiparasitic treatment of lesions caused by something else.
Limited imaging access can hide the true burden
Many communities with high transmission also have limited access to CT, MRI and specialist neurology.
A person may therefore be treated for epilepsy for years without the structural cause ever being identified.
This means neurocysticercosis can contribute to the epilepsy treatment and diagnostic gaps simultaneously.
Treatment is not simply ‘give a deworming tablet’
Management depends on lesion location, number, viability, inflammation, symptoms and complications.
Antiparasitic treatment can kill viable cysts, but killing parasites can temporarily increase inflammation. In the brain, that inflammatory response can worsen oedema, seizures or intracranial pressure.
For that reason, treatment must be selected and timed carefully rather than approached as routine intestinal deworming.
Albendazole and praziquantel have different roles
WHO and specialist guidelines recommend antiparasitic treatment for selected forms of viable parenchymal neurocysticercosis. Albendazole is commonly used, while combination therapy with albendazole and praziquantel may be recommended when there are multiple viable parenchymal cysts.
The exact regimen depends on disease pattern and guideline context.
Some forms of disease require prolonged or repeated therapy, while antiparasitic treatment may be inappropriate or unnecessary in others.
Corticosteroids are often given because treatment causes inflammation
When viable cysts are destroyed, antigen release can provoke an inflammatory reaction. Corticosteroids are therefore commonly used in conjunction with antiparasitic therapy to control cerebral inflammation.
The timing and dose depend on disease burden and location.
In severe subarachnoid disease, anti-inflammatory treatment can become a major part of long-term management.
Antiseizure medication treats the seizures, not the parasite
People who present with seizures are usually treated with antiseizure medication according to seizure type and clinical circumstances.
This controls seizure risk while the underlying infection and inflammation are addressed.
Stopping antiseizure medication later depends on factors such as seizure recurrence, residual lesions, calcification and ongoing inflammatory activity.
Some people can eventually stop antiseizure medication
A person who had seizures associated with a solitary resolving lesion and remains seizure-free may not necessarily require lifelong antiseizure therapy.
By contrast, recurrent seizures, persistent calcifications, multiple lesions or established epilepsy may justify longer treatment.
Withdrawal decisions should be individualised rather than based simply on whether antiparasitic therapy has finished.
Drug-resistant epilepsy can occur
Although many people respond to antiseizure medication, some develop persistent focal epilepsy.
Possible mechanisms include residual gliosis, calcified lesions, recurrent inflammation and, in some patients, associated hippocampal sclerosis.
People with continuing seizures despite appropriate treatment may need the same specialist drug-resistant epilepsy assessment used for other structural epilepsies.
Neurocysticercosis and hippocampal sclerosis can coexist
Research has identified an association between neurocysticercosis and hippocampal sclerosis in some people with chronic epilepsy.
The exact causal pathway remains debated. Repeated seizures, inflammation or other mechanisms may contribute.
This is an important example of how an infectious brain disease can leave a longer-term epileptogenic network even after the parasite itself is no longer viable.
Hydrocephalus can be life-threatening
Ventricular or subarachnoid cysts can obstruct cerebrospinal fluid pathways or produce inflammatory scarring.
The resulting hydrocephalus can cause severe headache, vomiting, altered consciousness, visual symptoms and neurological deterioration.
These forms may require neurosurgical treatment in addition to antiparasitic and anti-inflammatory therapy.
Surgery sometimes has a role
Neurosurgery may be required for hydrocephalus, ventricular cyst removal or other selected complications.
Modern endoscopic techniques can sometimes allow removal of ventricular cysts without open surgery.
The appropriate approach depends heavily on cyst location and local expertise.
Ocular cysticercosis changes treatment decisions
Cysticerci can occur in the eye. Killing an intraocular parasite with antiparasitic medication can provoke inflammation capable of damaging vision.
For this reason, clinicians may assess for ocular involvement before starting antiparasitic therapy in patients at risk.
This is another reason neurocysticercosis should not be self-treated with anti-parasitic drugs.
Spinal neurocysticercosis is uncommon but important
Rarely, cysts affect the spinal cord or spinal subarachnoid space.
Symptoms can include pain, weakness, sensory change and sphincter dysfunction rather than seizures.
Its rarity and varied presentation can make diagnosis difficult.
Endemicity is linked to poverty and sanitation
T. solium transmission persists where sanitation is inadequate, human faeces can contaminate the environment and pigs have access to that contamination.
Poverty can also limit meat inspection, veterinary services, diagnostic imaging and access to treatment.
The disease is therefore both an infection and a marker of structural inequality.
Imported cases occur outside endemic countries
Migration and travel mean neurocysticercosis is diagnosed in Europe, North America and other regions where local transmission is uncommon.
A person may present with seizures years after leaving an endemic area because symptoms can be delayed.
Clinicians therefore need to consider lifetime residence and travel history rather than only current location.
Local transmission can occasionally occur in non-endemic settings
Because a human tapeworm carrier can shed infectious eggs, cysticercosis can occasionally occur in people who have never travelled to an endemic region.
Household or close-contact transmission is possible when sanitation and hand hygiene fail.
This reinforces the distinction between acquiring intestinal taeniasis from infected pork and acquiring cysticercosis from tapeworm eggs.
Prevention requires a One Health approach
No single intervention is enough to eliminate T. solium transmission.
Effective control can include improved sanitation, reliable water, treatment of human tapeworm carriers, improved pig husbandry, veterinary interventions, meat inspection, food hygiene and community education.
WHO emphasises integrated One Health strategies because human health, animal health and the environment are all part of the parasite’s life cycle.
Treating human tapeworm carriers breaks transmission
People with intestinal T. solium taeniasis may have few or no symptoms but can shed large numbers of infectious eggs.
Identifying and treating carriers reduces contamination and therefore protects both pigs and other people.
Community-level preventive chemotherapy may be considered in some endemic settings according to WHO guidance.
Sanitation is one of the most powerful interventions
Safe disposal of human faeces prevents pigs and people from coming into contact with T. solium eggs.
Latrines, sewage infrastructure, clean water and hand hygiene are therefore direct neurological prevention measures.
This is why neurocysticercosis sits at the intersection of neglected tropical disease control and epilepsy prevention.
Pig management matters
Pigs become infected when they have access to human faecal contamination. Keeping pigs enclosed, providing safe feed and improving veterinary oversight can interrupt this part of the life cycle.
Vaccination and antiparasitic treatment of pigs can also contribute to control programmes in some settings.
These interventions protect household income as well as human health.
Meat inspection reduces taeniasis risk
Inspection can identify heavily infected pork before it reaches consumers, while thorough cooking destroys cysticerci.
This reduces human intestinal taeniasis and therefore reduces the number of tapeworm carriers able to contaminate the environment with eggs.
Food safety is therefore one component of preventing neurocysticercosis even though eating pork cysts does not directly cause cysticercosis.
Education has to explain the life cycle correctly
If communities are told simply that ‘pork causes epilepsy’, prevention messages can become inaccurate and stigmatising.
The more useful message is that undercooked infected pork can create a human tapeworm carrier, while neurocysticercosis occurs when people swallow eggs shed by such carriers.
Understanding the full cycle supports sanitation, hand hygiene and treatment rather than blame.
Epilepsy stigma can hide transmission-related disease
WHO notes that people with epilepsy caused by neurocysticercosis can experience substantial stigma, particularly in poor rural communities where seizures may be attributed to witchcraft or supernatural causes.
Stigma can delay biomedical care and make surveillance less accurate.
Control programmes therefore need epilepsy education alongside parasite control.
Women and girls may face disproportionate social consequences
In some communities, epilepsy can affect marriage prospects, education, employment and social participation, with particularly severe consequences for women and girls.
The biological infection is the same, but the social cost is shaped by gender and culture.
Preventing neurocysticercosis can therefore reduce both neurological disease and some of the social harms attached to epilepsy.
The true global burden remains uncertain
WHO notes that detailed epidemiological data are incomplete. Many endemic regions have limited neuroimaging, laboratory diagnostics and surveillance.
As a result, both infection prevalence and the fraction of epilepsy attributable to neurocysticercosis are uncertain in many countries.
The often-cited 30% figure is an estimate for endemic areas, not a universal percentage for all countries or all communities.
New WHO surveillance guidance aims to improve the data
In July 2026, WHO published new guidance on routine health information systems and health-facility data for T. solium taeniasis and cysticercosis.
Better surveillance can help countries identify transmission hotspots, monitor control programmes and understand where epilepsy associated with neurocysticercosis is being missed.
This matters because diseases that are poorly measured are easily under-prioritised.
Elimination is theoretically possible but operationally difficult
The parasite depends on a transmission cycle that can be interrupted. Unlike many genetic or developmental causes of epilepsy, neurocysticercosis is therefore fundamentally preventable.
But sustained control requires coordinated human treatment, sanitation, veterinary interventions, food safety and community participation.
Stopping one part of the cycle temporarily is rarely enough if the others remain intact.
Why this disease matters to the global epilepsy story
Neurocysticercosis demonstrates that epilepsy epidemiology is shaped by more than neurology.
A person’s risk of developing epilepsy can depend on sanitation infrastructure, pig farming, meat inspection, poverty, access to imaging and whether an asymptomatic tapeworm carrier receives treatment.
It is one of the clearest examples of why global epilepsy prevention requires public health, veterinary medicine and social investment as well as antiseizure medication.
What this page does — and does not — explain
This page focuses specifically on neurocysticercosis as a cause of seizures and epilepsy. The wider group of infection-related epilepsies is covered under Epilepsy After CNS Infection, while the broader public-health context is covered on Preventable Causes of Epilepsy Worldwide.
Sources
World Health Organization — Taeniasis/cysticercosis fact sheet
WHO — Taeniasis and cysticercosis questions and answers, 2025
WHO — Guidelines on management of Taenia solium neurocysticercosis
WHO — Routine health information system guidance for Taenia solium taeniasis and cysticercosis, 2026
Garcia et al. — Neurocysticercosis: a frequent cause of seizures, epilepsy and neurological morbidity
Epidemiology of neurocysticercosis and epilepsy
Neurocysticercosis as an infectious acquired epilepsy worldwide
Evidence checked: September 2026.